[双向教学方法在情侣背景下对心力衰竭管理]
Judith Makana1, Viola Polomeno2
1Hôpital Montfort, 713 chemin Montréal, Ottawa, Ontario, K1K 0T2, Canada.
Soins. Gerontologie
|November 7, 2024
概括
伴侣的参与增强了心力衰竭 (HF) 的自我护理. 使用回教方法的教育课程通过确保对病情的理解和积极参与来改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 患者教育 患者教育
- 医疗保健管理的管理
背景情况:
- 心力衰竭 (HF) 管理需要患者和护理人员积极参与.
- 有效的患者教育对于改善HF的自我护理和临床结果至关重要.
- 现有的教育策略可能无法完全让合作伙伴参与HF自我护理过程.
研究的目的:
- 强调伴侣参与心力衰竭自我护理的重要性.
- 促进回教方法用于心力衰竭教育的使用.
- 为医疗保健专业人员,特别是法语护士提供有效的反教策略.
主要方法:
- 利用以回教方法为重点的教育课程.
- 为管理心力衰竭的夫妇开发一个关于自我照顾的特定课程组件.
- 培训医疗保健工作人员,包括法语护士,实施回教方法.
主要成果:
- 积极的合作伙伴参与显著促进了更好的心力衰竭自我护理.
- 回教方法提高了患者和合作伙伴对高温管理的理解.
- 医疗保健工作人员可以得到有效的培训,以实施这种双重重点的教育战略.
结论:
- 将合作伙伴纳入心力衰竭自我护理管理是非常有益的.
- 回教方法是改善HF患者教育和坚持治疗的强大工具.
- 在这种方法中培训医疗保健提供者可以提高HF夫妇的护理质量.
相关概念视频
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
Heart Failure Drugs: Inotropic Agents
523
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
523
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345


